Protalix BioTherapeutics
PLX
#8815
Rank
S$0.22 B
Marketcap
S$2.81
Share price
-0.45%
Change (1 day)
-16.01%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): S$9.9 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are S$61.84 Million. In 2024 the company made an earning of S$6.64 Million a decrease over its 2023 earnings that were of S$14.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$9.9 M49.12%
2024 S$6.64 M-55.62%
2023 S$14.96 M-199.05%
2022 -S$15.12 Million-40.38%
2021 -S$25.35 Million-732.31%
2020 S$4 M-130.53%
2019 -S$13.13 Million189.85%
2018 -S$4.53 Million-95.29%
2017 -S$96.2 Million308.12%
2016 -S$23.58 Million-32.37%
2015 -S$34.86 Million10.11%
2014 -S$31.66 Million-7.59%
2013 -S$34.26 Million
2011 -S$39.67 Million-19.39%
2010 -S$49.21 Million20.87%
2009 -S$40.71 Million32.26%
2008 -S$30.78 Million-5.46%
2007 -S$32.56 Million
2004 -S$0.22 Million12.35%
2003 -S$0.19 Million-11.1%
2002 -S$0.22 Million-57.03%
2001 -S$0.5 Million1.03%
2000 -S$0.49 Million-53.22%
1999 -S$1.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$12.97 B 136,540.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.81 B 8,433.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.24 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.74 B 28,751.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel